We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

6818:HKEXChina Everbright Bank Co., Ltd. Class H Analysis

Data as of 2026-03-15 - not real-time

HK$3.26

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

China Everbright Bank (6818.HK) is trading at HK$3.26, comfortably below its 20‑day (3.322) and 50‑day (3.363) SMAs and approaching the identified support level of HK$3.19, signaling short‑term bearish pressure. Technical indicators are mixed: RSI sits at 43 (neutral), the MACD histogram has turned positive and the MACD signal is deemed bullish, while volume is on an upward trend, suggesting potential for a near‑term bounce. Fundamentally, the stock appears markedly undervalued with a trailing P/E of 4.79 versus an industry average of 16.35 and a P/B of 0.34, while offering an attractive dividend yield of 6.43% and a modest payout ratio of 31%, indicating dividend sustainability. Analyst consensus is a “hold” with a mean target of HK$3.87, implying roughly 18% upside, and the market sentiment index is in “greed” territory (72.88), reflecting broader optimism.
The bank’s profitability metrics are solid (operating margin 62%, profit margin 44%) despite flat revenue growth (-0.1%) and modest ROE (6.8%). A low beta of 0.14 points to limited market‑wide volatility, although 30‑day price volatility is elevated at ~19% and the historical max drawdown reached -22.7%, flagging price risk. Strong cash reserves (HK$1.04 trn) offset a sizable debt load, and the low valuation coupled with a high dividend makes the stock attractive for value‑oriented investors seeking income and potential upside.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near support level of HK$3.19
  • Mixed technical signals with bullish MACD but bearish SMA alignment
  • High dividend yield providing downside cushion

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Significant valuation gap (P/E 4.79 vs industry 16.35)
  • Analyst target price suggesting ~18% upside
  • Sustainable dividend supporting total return

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong profitability and cash generation
  • Low beta indicating stability in broader market moves
  • Consistent dividend policy enhancing long‑term yield

Key Metrics & Analysis

Financial Health

Revenue Growth-10.00%
Profit Margin43.68%
P/E Ratio4.8
ROE6.84%
ROA0.58%
P/B Ratio0.3
Op. Cash FlowHK$25.6B
Industry P/E16.4

Technical Analysis

TrendBearish
RSI43.0
SupportHK$3.19
ResistanceHK$3.49
MA 20HK$3.32
MA 50HK$3.36
MA 200HK$3.57
MACDBullish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

Target PriceHK$3.87
Upside/Downside18.72%
GradeUndervalued
TypeValue
Dividend Yield6.43%

Risk Assessment

Beta0.14
Volatility18.96%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.